137 related articles for article (PubMed ID: 3702053)
1. [Clinical studies on the biliary excretion of mezlocillin, especially in cases with liver dysfunction].
Maeba T; Hashimoto T; Takeda T; Shiraishi Y; Oike H; Wakabayashi H; Omori G; Indo S; Kunikata E; Hayashi M
Jpn J Antibiot; 1986 Jan; 39(1):116-20. PubMed ID: 3702053
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy of biliary tract infections (XXIV). Biliary excretion and gallbladder tissue levels of mezlocillin].
Kobayashi N; Tanimura H; Huang WF; Sekiya T; Takahashi H; Sato T; Yoshida K; Hikasa Y
Jpn J Antibiot; 1984 Apr; 37(4):597-604. PubMed ID: 6471380
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic therapy in biliary tract infections: clinical experiences with mezlocillin.
Cristiano P; Iovene MR; Cioffi R; Salerno RA; Sicolo A; Cristinzio G; Paradisi F
Chemioterapia; 1984 Jun; 3(3):178-82. PubMed ID: 6529774
[TBL] [Abstract][Full Text] [Related]
4. [Bacterial elimination and antibiotic concentration in the gall-bladder during biliary tract infections treated with mezlocillin (author's transl)].
Helm EB; Wurbs D; Gundlach H; Beyer B; Hagenmüller F; Stille W
Dtsch Med Wochenschr; 1981 Aug; 106(35):1087-90. PubMed ID: 6455282
[TBL] [Abstract][Full Text] [Related]
5. Biliary excretion of mezlocillin in patients with hepatic disease.
Hildebrandt R; Gundert-Remy U; Raedsch R; Sieg A; Stiehl A
Int J Clin Pharmacol Ther; 1995 Jul; 33(7):384-7. PubMed ID: 7582392
[TBL] [Abstract][Full Text] [Related]
6. [Biliary excretion and clinical evaluation of cefoperazone in the biliary tract infections].
Koizumi M; Simosegawa T; Yanbe M; Goto Y; Sugawara H; Kanno Y; Kanazawa Y; Kai Y; Sato T; Endou K
Jpn J Antibiot; 1986 Jul; 39(7):1663-70. PubMed ID: 3773263
[TBL] [Abstract][Full Text] [Related]
7. Biliary elimination of mezlocillin: an experimental and clinical study.
Brogard JM; Kopferschmitt J; Arnaud JP; Dorner M; La Villaureix J
Antimicrob Agents Chemother; 1980 Jul; 18(1):69-76. PubMed ID: 6448023
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of mezlocillin in patients with hepatobiliary dysfunction.
Meyers BR; Srulevitch ES; Sacks HS; Hirschman SZ; Worner TM; Wormser GP; Jacobson J
J Antimicrob Chemother; 1986 Dec; 18(6):709-13. PubMed ID: 3818496
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic concentration in bile from patients with obstructive jaundice. I: Variations of sulbenicillin concentration in bile.
Ker CG; Peng CF; Hsieh JS; Huang TJ; Sheen PC
Taiwan Yi Xue Hui Za Zhi; 1980 Sep; 79(9):768-73. PubMed ID: 6939790
[No Abstract] [Full Text] [Related]
10. Cefepime for infections of the biliary tract.
Thompson JE; Bennion RS; Roettger R; Lally KP; Hopkins JA; Wilson SE
Surg Gynecol Obstet; 1993; 177 Suppl():30-4; discussion 35-40. PubMed ID: 8256189
[TBL] [Abstract][Full Text] [Related]
11. The biliary excretion and pharmacokinetics of mezlocillin in jaundiced patients with external bile drainage.
Dooley JS; Gooding A; Hamilton-Miller JM; Brumfitt W; Sherlock S
Liver; 1983 Aug; 3(4):201-6. PubMed ID: 6672502
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis.
Gerecht WB; Henry NK; Hoffman WW; Muller SM; LaRusso NF; Rosenblatt JE; Wilson WR
Arch Intern Med; 1989 Jun; 149(6):1279-84. PubMed ID: 2658897
[TBL] [Abstract][Full Text] [Related]
13. [Bile composition and antibiotic excretion. Observations with T-drainage].
Rosenthal RJ; Steigerwald SD; Bockhorn H
Z Gesamte Inn Med; 1993 Jan; 48(1):18-22. PubMed ID: 8095119
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy on the biliary tract infections. XIII. Miloxacin, a novel chemotherapeutic agent, its excretion into bile and clinical effect on the biliary tract infections (author's transl)].
Jpn J Antibiot; 1981 Sep; 34(9):1335-52. PubMed ID: 7328756
[TBL] [Abstract][Full Text] [Related]
15. [Laboratory and clinical investigations of cefotiam in surgical biliary tract infections].
Oikawa M; Watanabe I
Jpn J Antibiot; 1982 May; 35(5):1153-62. PubMed ID: 6290699
[TBL] [Abstract][Full Text] [Related]
16. Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract.
Schwab D; Grauer M; Hahn EG; Mühldorfer S
Aliment Pharmacol Ther; 2005 Sep; 22(5):417-22. PubMed ID: 16128679
[TBL] [Abstract][Full Text] [Related]
17. [Clinical experiences with cefmetazole for peritonitis and biliary tract infections with special reference to excretion of cefmetazole into bile (author's transl)].
Saito T; Yamada Y; Yokoyama S
Jpn J Antibiot; 1979 Apr; 32(4):504-8. PubMed ID: 459081
[No Abstract] [Full Text] [Related]
18. [Chemotherapy of biliary tract infections (XXXVII). Excretion into bile and gallbladder tissue levels of levofloxacin and its clinical effect in biliary tract infections].
Tanimura H; Ohnishi H; Okamura T; Uenishi M; Ichimiya G; Kobayashi Y; Aoki Y; Oka S; Yamamoto S; Shimada K
Jpn J Antibiot; 1992 May; 45(5):557-68. PubMed ID: 1512942
[TBL] [Abstract][Full Text] [Related]
19. [Experimental study and human pharmacology of the biliary excretion of a cephalosporin, cephalexin. Therapeutical application].
Brogard JM; Kuntzmann F; Dorner M; Haegele P; Lavillaureix J
Pathol Biol (Paris); 1971 Dec; 19(23):1121-31. PubMed ID: 4945763
[No Abstract] [Full Text] [Related]
20. Antibiotics in the treatment of biliary infection.
Dooley JS; Hamilton-Miller JM; Brumfitt W; Sherlock S
Gut; 1984 Sep; 25(9):988-98. PubMed ID: 6381248
[No Abstract] [Full Text] [Related]
[Next] [New Search]
